ArticleCureus2025
Mental Health and Quality of Life in Glaucoma Patients: Insights From a Comparative Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of family members towards glaucoma medication adherence.Indian journal of ophthalmology · 2026Article
- Multimodal AI-based modeling of glaucoma progression: a 3PM-guided approach integrating structural, functional, and vascular patterns.The EPMA journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Glaucoma, a chronic and progressive optic neuropathy, is a leading cause of irreversible blindness, affecting both visual function and quality of life (QoL). The disease's progression, alongside the fear of blindness, contributes to anxiety, depression, and reduced life satisfaction. This study aimed to evaluate the impact of glaucoma on mental health and QoL and to examine the relationship between glaucoma severity and psychological and functional factors. Methods A cross-sectional study was conducted involving 102 patients with glaucoma and 82 age-matched controls without significant ocular disease. All participants completed the 12-Item Short-Form Health Survey version 2 (SF-12v2) to assess general health and the Glaucoma QoL Questionnaire (Glau-QoL-17) for disease-specific QoL. Additional demographic and clinical data, such as education level, household composition, driving status, type of glaucoma, best-corrected visual acuity, number of antiglaucoma medications, static automated perimetry results, psychiatric comorbidities, use of psychiatric medications, and disease-related anxiety were also recorded. Results Glaucoma patients had a mean age of 72.3 ± 7.6 years, with 52.0% (n=53) being female, compared to a mean age of 70.1 ± 18.2 years in the control group, with a female population of 51.2% (n=49). Glaucoma patients scored significantly lower in general health compared to controls (Physical component score: 41.3 ± 11.3 vs. 49.7 ± 8.3
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.